Xcout IntelInspireMD Inc.
InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases. The company's offerings, distributed through a network of local partners, reach markets across Europe, Latin America, the Middle East, and Asia Pacific. Key products include the CGuard carotid embolic prevention system, specifically designed for carotid artery procedures, and the MGuard Prime embolic protection systems. The MGuard Prime systems are crucial for patients experiencing acute coronary syndromes, notably acute myocardial infarction, and those undergoing saphenous vein graft coronary interventions or bypass surgery. InspireMD is also developing PVGuard, an innovative solution combining a MicroNet mesh sleeve with a self-expandable stent, aimed at peripheral vascular applications.
Subscribe to see InspireMD Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
InspireMD Inc. at a glance
InspireMD Inc. is a medical - devices company headquartered in Tel Aviv, Israel. It is publicly listed (NSPR) with a market capitalisation of $32M. Xcout tracks 37 named people at InspireMD Inc., including Marvin L. Slosman (President, Chief Executive Officer & Director).
InspireMD Inc. leadership
- Marvin L. SlosmanPresident, Chief Executive Officer & Director
- Marvin SlosmanCEO
- Michael A. LawlessCFO, Secretary & Treasurer
- Michael LawlessCFO
- Peter A. SoukasChief Medical Officer
- Peter SoukasChief Medical Advisor
31 more named people on record for InspireMD Inc., with roles, board committees and tenure — see the full roster →
InspireMD Inc. competitors
A few of InspireMD Inc.'s closest competitors — see the full list of competitors and alternatives →
Rapid Medical is a medical device company headquartered in Yokneam, Israel, specializing in neurovascular therapy solutions. The company develops advanced medical technologies, such as the DRIVEWIRE 35, and provides innovative treatments for stroke cases globally.
Restore Medical is a clinical-stage medical technology company based in Israel that develops cardiac implants and transcatheter therapies for the treatment of congestive heart failure.
Keystone Heart was an Israeli medical-device company that developed cerebral embolic protection systems, including the TriGuard device, to help prevent debris from reaching the brain during transcatheter heart procedures such as TAVR. It served interventional cardiologists and structural-heart patients undergoing catheter-based valve interventions.
Established in 2004 and headquartered in Shanghai, People's Republic of China, MicroPort NeuroTech Limited is dedicated to the research, development, manufacturing, and global commercialization of neuro-interventional medical devices. The company's diverse product portfolio addresses various cerebrovascular conditions. For treating hemorrhagic stroke, it offers the NUMEN coil embolization system, the NUMEN FR coil detachment system, the Tubridge flow-diverting stent, the Willis intracranial stent graft system, and the Rebridge intracranial visualized stent. Additionally, MicroPort NeuroTech supplies the APOLLO intracranial arterial stent system for intracranial atherosclerotic disease, as well as the Bridge rapamycin target eluting vertebral artery stent system specifically designed for cerebral atherosclerotic stenosis. To address acute ischemic stroke, the company provides the Neurohawk stent thrombectomy device and the Tigertriever adjustable stent retriever.
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
RenalGuard Solutions, Inc. develops the RenalGuard System, a medical device intended to help prevent contrast-induced acute kidney injury by maintaining high urine output during procedures involving contrast media. Its customers include hospitals and interventional cardiology teams performing catheterization and other contrast-based procedures.
Get InspireMD Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on InspireMD Inc. in Xcout Intel
- 37 named people with titles, LinkedIn and board committees
- 3 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access